Stocks Health care TLSA
NASDAQ · Health careTiziana Life Sciences Ltd (TLSA)
It posted a net loss of $11.9M. In fiscal 2024 capital spending exceeded operating cash flow by $1.5M. At December 31, 2024 it held $3.7M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on May 1, 2026.
Key facts about Tiziana Life Sciences Ltd
- Net worth
- Tiziana Life Sciences Ltd has a market value (market cap) of $77.7M at the latest share price, and shareholders' equity of $3.9M on its balance sheet at December 31, 2024. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2024 operations used $1.5M of cash.
- Latest report
- The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on May 1, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR
What Tiziana Life Sciences Ltd does
Tiziana Life Sciences Ltd is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker TLSA.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | n/a | -$11.9M | -$0.11 | -$1.5M |
| 2023 | n/a | -$17.7M | -$0.17 | n/a |
| 2022 | n/a | -$15.4M | -$0.15 | n/a |
| 2021 | n/a | -$23.4M | -$0.24 | -$21.8M |
| 2020 | n/a | -$26.1M | -$0.16 | -$11.3M |
| 2019 | n/a | -$9.3M | -$0.07 | -$6.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Tiziana Life Sciences Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 9, 2026
- November 9, 2026
- November 5, 2026
- November 2, 2026
- November 2, 2026
- October 21, 2026
- October 16, 2026
- October 16, 2026
- September 30, 2026
- September 28, 2026
Insider trades
What the people running Tiziana Life Sciences Ltd did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 1 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| August 15, 2026 | Elrifi IvorChief Executive Officer | Exercised optionsindirect | 1,050,000 | - |
| August 5, 2026 | Elrifi IvorChief Executive Officer | Boughtindirect | 237,616 | $237.6K |
| August 4, 2026 | Elrifi IvorChief Executive Officer | Boughtindirect | 83,807 | $81.3K |
| August 3, 2026 | Elrifi IvorChief Executive Officer | Boughtindirect | 667,000 | $667K |
| July 21, 2026 | Cerrone Gabriele MDirector, 10% owner | Boughtindirect | 42,357 | $41.9K |
| July 21, 2026 | Cerrone Gabriele MDirector, 10% owner | Received as payindirect | 42,357 | $41.9K |
| June 12, 2026 | Cerrone Gabriele MDirector, 10% owner | Boughtindirect | 15,000 | $16.7K |
| June 12, 2026 | Cerrone Gabriele MDirector, 10% owner | Received as payindirect | 15,000 | $16.7K |
Who owns TLSA
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Laura Natalia Monica Fonda13G, passive | 5.7% | October 28, 2025 |
| Chernett Jorey13G, passive | 5.4% | December 10, 2025 |
Largest institutional holders
Insiders
2 insiders reported holding 50,658,271 shares in total, about $30.9M at the last price.
| Holder | Shares |
|---|---|
| Cerrone Gabriele MDirector, 10% owner | 44,814,58744,814,587 held indirectly |
| Elrifi IvorChief Executive Officer | 5,843,6845,843,684 held indirectly |
Questions about TLSA
What does Tiziana Life Sciences Ltd do?
Tiziana Life Sciences Ltd is a company in the Health care sector, listed on NASDAQ as TLSA. Its shares trade on NASDAQ under the ticker TLSA.
What is Tiziana Life Sciences Ltd's net worth?
Tiziana Life Sciences Ltd has a market value (market cap) of $77.7M at the latest share price, and shareholders' equity of $3.9M on its balance sheet at December 31, 2024. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Tiziana Life Sciences Ltd profitable?
No. In fiscal 2024 it reported a net loss of $11.9M.
When did Tiziana Life Sciences Ltd last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on May 1, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from November 9, 2026.
Similar companies
Compare TLSA with
Follow TLSA
Get an email when Tiziana Life Sciences Ltd files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Tiziana Life Sciences Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.